Posted on Leave a comment

Cagrilintide Research Peptide: Pre-Clinical Guide & Wholesale Supply

In short: Cagrilintide is a long-acting, acylated analogue of the hormone amylin and an unapproved investigational compound, supplied by Vexar Lab strictly for in-vitro laboratory research and not approved for human consumption. It is a current reference compound in amylin-receptor and metabolic research. Before ordering any peptide, research buyers should confirm purity of at least 99% by HPLC, identity confirmation by mass spectrometry, and clear batch numbering with a corresponding certificate of analysis (COA).

What is Cagrilintide?

Cagrilintide is a synthetic, long-acting amylin analogue developed by Novo Nordisk as a once-weekly, acylated peptide. It is described in the literature as a non-selective amylin-receptor agonist acting at calcitonin and amylin receptor complexes. It remains an investigational, proprietary compound: as of 2026 it is not approved by the FDA or EMA, and much of its development has focused on the combination with semaglutide known as CagriSema, which is also not approved. Researchers use cagrilintide as a tool to study long-acting amylin-receptor pharmacology.

What does the research investigate?

Published research, including Phase 2 and Phase 3 clinical programmes, has investigated cagrilintide’s effects on amylin-receptor signalling, food intake, body weight, and glycaemic control, both as a monotherapy and in combination with GLP-1 receptor agonists. Trials have also examined its role in bone metabolism. As an unapproved investigational drug, all reported effects are research findings only and do not establish safety or efficacy for any general human use; the compound is not authorised for therapeutic use in any market. Always read the primary sources directly.

Purity and quality: what research buyers should check

  • Purity of at least 99% by HPLC — confirm the figure against the batch-specific COA rather than a generic specification sheet.
  • Identity confirmation by mass spectrometry — the measured mass should match the expected molecular weight of the peptide.
  • Batch numbering — every vial should trace back to a documented production batch and its analytical records.

Vexar Lab supplies Cagrilintide as a pack of 10 vials, ≥99% HPLC-verified, batch-numbered, with mass-spec confirmation.

Handling and storage

Cagrilintide is supplied lyophilised. Standard laboratory practice for lyophilised peptides applies: store the sealed vials cold and protected from light, reconstitute only with an appropriate sterile solvent immediately before use, and aliquot to avoid repeated freeze-thaw cycles. Reconstituted peptide is generally less stable than the dry powder and should be kept refrigerated and used within a short working window. Follow your own institution’s handling protocols.

Wholesale supply

Vexar Lab supplies Cagrilintide to research buyers and resellers in packs of 10 vials, with a £300 minimum order, bulk pricing on volume, £45 flat worldwide shipping, and optional custom labelling for resellers.

Frequently asked questions

Is Cagrilintide approved for human use?

No. Cagrilintide is an unapproved investigational compound, supplied by Vexar Lab strictly as a research material for in-vitro laboratory use. It is not sold for human consumption, and nothing here constitutes medical or dosing guidance.

What purity does Vexar Lab guarantee?

Each batch is verified at ≥99% by HPLC with identity confirmed by mass spectrometry, and every vial is batch-numbered against its COA.

How is it shipped and packaged?

It ships lyophilised in packs of 10 vials, with £45 flat worldwide shipping and batch documentation available on request.

This guide is provided for research-only purposes. Cagrilintide is an unapproved investigational compound supplied strictly for in-vitro laboratory research and is not approved for human consumption. No medical, therapeutic, or dosing advice is given or implied.


Related: GLP-1 research peptides · Lab standards & purity testing · Shop all research peptides · How to buy research peptides wholesale

Posted on Leave a comment

MOTS-c Research Peptide: Pre-Clinical Guide & Wholesale Supply

In short: MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA gene, supplied by Vexar Lab strictly for in-vitro laboratory research and not approved for human consumption. It is a widely studied tool compound in metabolic and mitochondrial-signalling research. Before ordering any peptide, research buyers should confirm purity of at least 99% by HPLC, identity confirmation by mass spectrometry, and clear batch numbering with a corresponding certificate of analysis (COA).

What is MOTS-c?

MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a short peptide notable for being encoded by mitochondrial DNA rather than the nuclear genome — one of the first peptides discovered to be produced this way. This finding helped establish that mitochondria actively signal to the rest of the cell through dedicated peptides. In research it is described as a regulator of cellular metabolism that circulates in the bloodstream and acts on metabolic tissues, making it a frequently used reference compound in studies of mitochondrial-to-nuclear communication.

What does the research investigate?

Pre-clinical literature has examined MOTS-c chiefly for its reported activation of the AMPK pathway, effects on glucose uptake in skeletal muscle, and modulation of the folate-methionine cycle. Because circulating levels are reported to rise with exercise in some studies, it is often referred to in the literature as an “exercise mimetic.” Animal research has explored its role in diet-induced metabolic dysfunction, insulin sensitivity, and age-related metabolic changes. These are investigational findings from cell and animal models and do not establish safety or efficacy for any human use. Always read the primary sources directly.

Purity and quality: what research buyers should check

  • Purity of at least 99% by HPLC — confirm the figure against the batch-specific COA rather than a generic specification sheet.
  • Identity confirmation by mass spectrometry — the measured mass should match the expected molecular weight of the peptide.
  • Batch numbering — every vial should trace back to a documented production batch and its analytical records.

Vexar Lab supplies MOTS-c as a pack of 10 vials, ≥99% HPLC-verified, batch-numbered, with mass-spec confirmation.

Handling and storage

MOTS-c is supplied lyophilised. Standard laboratory practice for lyophilised peptides applies: store the sealed vials cold and protected from light, reconstitute only with an appropriate sterile solvent immediately before use, and aliquot to avoid repeated freeze-thaw cycles. Reconstituted peptide is generally less stable than the dry powder and should be kept refrigerated and used within a short working window. Follow your own institution’s handling protocols.

Wholesale supply

Vexar Lab supplies MOTS-c to research buyers and resellers in packs of 10 vials, with a £300 minimum order, bulk pricing on volume, £45 flat worldwide shipping, and optional custom labelling for resellers.

Frequently asked questions

Is MOTS-c approved for human use?

No. Vexar Lab supplies MOTS-c strictly as a research material for in-vitro laboratory use. It is not sold for human consumption, and nothing here constitutes medical or dosing guidance.

What purity does Vexar Lab guarantee?

Each batch is verified at ≥99% by HPLC with identity confirmed by mass spectrometry, and every vial is batch-numbered against its COA.

How is it shipped and packaged?

It ships lyophilised in packs of 10 vials, with £45 flat worldwide shipping and batch documentation available on request.

This guide is provided for research-only purposes. MOTS-c is supplied strictly for in-vitro laboratory research and is not approved for human consumption. No medical, therapeutic, or dosing advice is given or implied.


Related: Metabolic research peptides · Lab standards & purity testing · Shop all research peptides · How to buy research peptides wholesale

Posted on Leave a comment

Epithalon Research Peptide: Pre-Clinical Guide & Wholesale Supply

In short: Epithalon (also written Epitalon) is a synthetic tetrapeptide, Ala-Glu-Asp-Gly (AEDG), modelled on a pineal-gland peptide, supplied by Vexar Lab strictly for in-vitro laboratory research and not approved for human consumption. It is a widely cited tool compound in telomere and longevity research. Before ordering any peptide, research buyers should confirm purity of at least 99% by HPLC, identity confirmation by mass spectrometry, and clear batch numbering with a corresponding certificate of analysis (COA).

What is Epithalon?

Epithalon is a short four-amino-acid peptide bioregulator (Ala-Glu-Asp-Gly) developed by Vladimir Khavinson and colleagues, derived from study of the pineal extract epithalamin. As one of the simplest synthetic peptide bioregulators, it is often used as a reference compound in research on short peptides that are proposed to interact with DNA and gene-regulatory processes. Much of the foundational work was conducted at the St. Petersburg Institute of Bioregulation and Gerontology, with independent laboratories more recently revisiting its reported effects.

What does the research investigate?

In cell-culture and animal models, epithalon has been studied chiefly for reported activation of telomerase and telomere elongation in somatic cells, for effects on pineal melatonin rhythm and circadian function, and for changes in lifespan and age-related markers in model organisms. Some animal studies report extended lifespan without increased tumour incidence, and the literature also describes effects on immune-related signalling and various enzyme activities. The precise mechanisms remain uncertain and these are investigational pre-clinical findings that do not establish human safety or efficacy. Always read the primary sources directly.

Purity and quality: what research buyers should check

  • Purity of at least 99% by HPLC — confirm the figure against the batch-specific COA rather than a generic specification sheet.
  • Identity confirmation by mass spectrometry — the measured mass should match the expected molecular weight of the peptide.
  • Batch numbering — every vial should trace back to a documented production batch and its analytical records.

Vexar Lab supplies Epithalon as a pack of 10 vials, ≥99% HPLC-verified, batch-numbered, with mass-spec confirmation.

Handling and storage

Epithalon is supplied lyophilised. Standard laboratory practice for lyophilised peptides applies: store the sealed vials cold and protected from light, reconstitute only with an appropriate sterile solvent immediately before use, and aliquot to avoid repeated freeze-thaw cycles. Reconstituted peptide is generally less stable than the dry powder and should be kept refrigerated and used within a short working window. Follow your own institution’s handling protocols.

Wholesale supply

Vexar Lab supplies Epithalon to research buyers and resellers in packs of 10 vials, with a £300 minimum order, bulk pricing on volume, £45 flat worldwide shipping, and optional custom labelling for resellers.

Frequently asked questions

Is Epithalon approved for human use?

No. Vexar Lab supplies epithalon strictly as a research material for in-vitro laboratory use. It is not sold for human consumption, and nothing here constitutes medical or dosing guidance.

What purity does Vexar Lab guarantee?

Each batch is verified at ≥99% by HPLC with identity confirmed by mass spectrometry, and every vial is batch-numbered against its COA.

How is it shipped and packaged?

It ships lyophilised in packs of 10 vials, with £45 flat worldwide shipping and batch documentation available on request.

This guide is provided for research-only purposes. Epithalon is supplied strictly for in-vitro laboratory research and is not approved for human consumption. No medical, therapeutic, or dosing advice is given or implied.


Related: Longevity & immune research peptides · Lab standards & purity testing · Shop all research peptides · How to buy research peptides wholesale

Posted on Leave a comment

PT-141 Research Peptide: Pre-Clinical Guide & Wholesale Supply

In short: PT-141 (bremelanotide) is a cyclic heptapeptide derived from the α-MSH analogue Melanotan II, supplied by Vexar Lab strictly for in-vitro laboratory research and not approved for human consumption. It is a well-characterised tool compound for studying melanocortin-receptor signalling in pre-clinical models. Before ordering any peptide, research buyers should confirm purity of at least 99% by HPLC, identity confirmation by mass spectrometry, and clear batch numbering with a corresponding certificate of analysis (COA).

What is PT-141?

PT-141 is a cyclic seven-amino-acid peptide that acts as a melanocortin-receptor agonist, with reported selectivity for the MC3 and MC4 receptor subtypes. It originated from work on α-melanocyte-stimulating hormone analogues at the University of Arizona, where Melanotan II was developed; PT-141 is a downstream, structurally distinct metabolite of that lineage. Its cyclic structure is reported to confer greater metabolic stability than linear α-MSH analogues. Because MC3R and MC4R are highly expressed in the hypothalamus and limbic system, PT-141 is frequently used as a reference agonist in central melanocortin research.

What does the research investigate?

Pre-clinical literature has used PT-141 to probe central melanocortin signalling, including MC3R/MC4R pharmacology, hypothalamic circuit function, autonomic modulation, and behavioural endpoints related to reward and arousal pathways in animal models. It is also cited in studies of blood-brain-barrier penetration by peptides. These are investigational findings from cell and animal research; they characterise receptor pharmacology and do not establish safety or efficacy for any human application. Always read the primary sources directly.

Purity and quality: what research buyers should check

  • Purity of at least 99% by HPLC — confirm the figure against the batch-specific COA rather than a generic specification sheet.
  • Identity confirmation by mass spectrometry — the measured mass should match the expected molecular weight of the peptide.
  • Batch numbering — every vial should trace back to a documented production batch and its analytical records.

Vexar Lab supplies PT-141 as a pack of 10 vials, ≥99% HPLC-verified, batch-numbered, with mass-spec confirmation.

Handling and storage

PT-141 is supplied lyophilised. Standard laboratory practice for lyophilised peptides applies: store the sealed vials cold and protected from light, reconstitute only with an appropriate sterile solvent immediately before use, and aliquot to minimise repeated freeze-thaw cycles. Reconstituted peptide is generally less stable than the dry powder and should be refrigerated and used within a short working window. Follow your own institution’s handling protocols.

Wholesale supply

Vexar Lab supplies PT-141 to research buyers and resellers in packs of 10 vials, with a £300 minimum order, bulk pricing on volume, £45 flat worldwide shipping, and optional custom labelling for resellers.

Frequently asked questions

Is PT-141 approved for human use?

No. Vexar Lab supplies PT-141 strictly as a research material for in-vitro laboratory use. It is not sold for human consumption, and nothing here constitutes medical or dosing guidance.

What purity does Vexar Lab guarantee?

Each batch is verified at ≥99% by HPLC with identity confirmed by mass spectrometry, and every vial is batch-numbered against its COA.

How is it shipped and packaged?

It ships lyophilised in packs of 10 vials, with £45 flat worldwide shipping and batch documentation available on request.

This guide is provided for research-only purposes. PT-141 is supplied strictly for in-vitro laboratory research and is not approved for human consumption. No medical, therapeutic, or dosing advice is given or implied.


Related: Hormonal research peptides · Lab standards & purity testing · Shop all research peptides · How to buy research peptides wholesale

Posted on Leave a comment

Tesamorelin Research Peptide: Pre-Clinical Guide & Wholesale Supply

In short: Tesamorelin is a synthetic 44-amino-acid analogue of growth hormone-releasing hormone (GHRH), supplied by Vexar Lab strictly for in-vitro laboratory research and not approved for human consumption. It is widely used as a tool compound for investigating the GH/IGF-1 axis in pre-clinical models. Research buyers should confirm three things before ordering any peptide: purity of at least 99% by HPLC, identity confirmation by mass spectrometry, and clear batch numbering with a corresponding certificate of analysis (COA).

What is Tesamorelin?

Tesamorelin is a stabilised analogue of human GHRH(1-44). Its structure is identical to native GHRH with a single modification — a trans-3-hexenoic acid group attached at the N-terminus — which is reported to slow enzymatic degradation and extend its functional half-life relative to unmodified GHRH. Mechanistically, it is studied as a GHRH-receptor agonist that acts on the anterior pituitary. Rather than introducing exogenous growth hormone, pre-clinical work describes it as amplifying the pituitary’s own pulsatile GH secretion. This makes it a frequently cited reference compound in studies of neuroendocrine signalling.

What does the research investigate?

Published pre-clinical and clinical literature has examined tesamorelin’s effects on the growth hormone/IGF-1 axis, on visceral adipose tissue, and on markers of lipid and glucose metabolism. In laboratory contexts it is used to probe GHRH-receptor pharmacology, pulsatile hormone release, and metabolic regulation. Tesamorelin is notable among GHRH analogues for having a substantial body of published study data, which makes it useful as a comparator. These findings are drawn from cell, animal, and controlled clinical research and do not establish safety or efficacy for any general human use. Always read the primary sources directly.

Purity and quality: what research buyers should check

  • Purity of at least 99% by HPLC — confirm the figure against the batch-specific COA rather than a generic specification sheet.
  • Identity confirmation by mass spectrometry — the measured mass should match the expected molecular weight of the peptide.
  • Batch numbering — every vial should trace back to a documented production batch and its analytical records.

Vexar Lab supplies Tesamorelin as a pack of 10 vials, ≥99% HPLC-verified, batch-numbered, with mass-spec confirmation.

Handling and storage

Tesamorelin is supplied lyophilised. Standard laboratory practice for lyophilised peptides applies: store the sealed vials cold and protected from light, reconstitute only with an appropriate sterile solvent immediately before use, and aliquot to avoid repeated freeze-thaw cycles. Reconstituted material is generally less stable than the lyophilised powder and should be kept refrigerated and used within a short working window. Always follow your own institution’s handling protocols.

Wholesale supply

Vexar Lab supplies Tesamorelin to research buyers and resellers in packs of 10 vials, with a £300 minimum order, bulk pricing on volume, £45 flat worldwide shipping, and optional custom labelling for resellers.

Frequently asked questions

Is Tesamorelin approved for human use?

No. Vexar Lab supplies tesamorelin strictly as a research material for in-vitro laboratory use. It is not sold for human consumption, and nothing here should be read as medical or dosing guidance.

What purity does Vexar Lab guarantee?

Each batch is verified at ≥99% by HPLC with identity confirmed by mass spectrometry, and every vial is batch-numbered against its COA.

How is it shipped and packaged?

It ships lyophilised in packs of 10 vials, with £45 flat worldwide shipping and batch documentation available on request.

This guide is provided for research-only purposes. Tesamorelin is supplied strictly for in-vitro laboratory research and is not approved for human consumption. No medical, therapeutic, or dosing advice is given or implied.


Related: Growth & IGF research peptides · Lab standards & purity testing · Shop all research peptides · How to buy research peptides wholesale

Posted on Leave a comment

Melanotan II Research Peptide: What It Is and What the Research Investigates

In short: Melanotan II is a synthetic cyclic peptide analogue of α-MSH, studied in pre-clinical models of melanocortin-receptor signalling and pigmentation biology. It is supplied strictly for laboratory research and is not approved for human use. For research buyers, the key purchasing criteria are verified purity (≥99% HPLC), confirmed identity (mass spectrometry) and batch traceability.

What is Melanotan II?

Melanotan II (MT-2) is a synthetic cyclic peptide analogue of alpha-melanocyte-stimulating hormone (α-MSH), developed to study melanocortin-receptor signalling. It acts as a non-selective agonist across multiple melanocortin receptors (MC1R, MC3R, MC4R and MC5R). It is a research compound only and is not a medicine — it is not approved by regulators for human, veterinary, cosmetic or therapeutic use.

What does the research investigate?

Published pre-clinical literature has examined Melanotan II in models of pigmentation pathways, melanocyte signalling, UV-response biology, appetite/metabolic signalling and neuroendocrine communication. Important: this research is largely in-vitro or in animals; findings in such models do not establish safety or efficacy in humans. Always read the primary sources directly.

Purity and quality: what research buyers should check

For reproducible research, compound quality is everything:

  • ≥99% purity by HPLC — confirm via the batch Certificate of Analysis.
  • Identity by mass spectrometry — confirms the correct molecular weight.
  • Batch numbering — traceability to a tested lot.

Vexar Lab supplies Melanotan II as a pack of 10 vials, ≥99% HPLC-verified, batch-numbered, with mass-spec confirmation.

Handling and storage

Follow standard lyophilised-peptide practice: store sealed vials appropriately, reconstitute with the diluent specified by your method, and record batch numbers in your lab notes.

Wholesale supply

Melanotan II is available wholesale: packs of 10 vials, £300 minimum order, bulk pricing on volume, £45 flat worldwide shipping, and optional custom labelling for resellers.

Frequently asked questions

Is Melanotan II approved for human use?

No. It is a research compound supplied for in-vitro laboratory research only and is not approved for human consumption or cosmetic use.

What receptors does it act on?

It is a non-selective melanocortin-receptor agonist (MC1R, MC3R, MC4R, MC5R) studied in pigmentation and signalling research.

How is it supplied?

As a pack of 10 vials, wholesale, with a £300 minimum order and £45 flat worldwide shipping.


Provided for research professionals. Melanotan II and all compounds referenced are intended strictly for in-vitro laboratory research and are not for human consumption. Verify all claims against primary literature and confirm local regulations before purchase.


Related: Tanning & Skin research peptides · Lab standards & purity testing · Shop all research peptides · How to buy research peptides wholesale

Posted on Leave a comment

Semax Research Peptide: What It Is and What the Research Investigates

In short: Semax is a synthetic heptapeptide derived from an ACTH fragment, studied in pre-clinical models of neurotrophic and neuromodulatory signalling. It is supplied strictly for laboratory research and is not approved for human use in most jurisdictions. For research buyers, the key purchasing criteria are verified purity (≥99% HPLC), confirmed identity (mass spectrometry) and batch traceability.

What is Semax?

Semax is a synthetic heptapeptide based on the ACTH(4-10) fragment of adrenocorticotropic hormone, with a C-terminal Pro-Gly-Pro sequence added to extend its stability. Unlike the parent hormone, it is not reported to stimulate adrenal steroidogenesis. It is used as a research compound; note that while Semax is an approved prescription medication in Russia, it is not approved or marketed in most other countries and here is supplied for in-vitro research only — it is not a medicine for human use.

What does the research investigate?

Published pre-clinical literature has examined Semax in models of brain-derived neurotrophic factor (BDNF) and TrkB signalling, and dopaminergic and serotonergic activity. Much of this work originates from Russian research groups and has not been replicated in large randomised Western trials. Important: these findings are largely in-vitro or in animals and do not establish safety or efficacy in humans. Always read the primary sources directly.

Purity and quality: what research buyers should check

For reproducible research, compound quality is everything:

  • ≥99% purity by HPLC — confirm via the batch Certificate of Analysis.
  • Identity by mass spectrometry — confirms the correct molecular weight.
  • Batch numbering — traceability to a tested lot.

Vexar Lab supplies Semax as a pack of 10 vials, ≥99% HPLC-verified, batch-numbered, with mass-spec confirmation.

Handling and storage

Follow standard lyophilised-peptide practice: store sealed vials appropriately, reconstitute with the diluent specified by your method, and record batch numbers in your lab notes.

Wholesale supply

Semax is available wholesale: packs of 10 vials, £300 minimum order, bulk pricing on volume, £45 flat worldwide shipping, and optional custom labelling for resellers.

Frequently asked questions

Is Semax approved for human use?

It is an approved prescription medicine in Russia, but it is not approved in most other countries. Here it is supplied for in-vitro laboratory research only and is not for human consumption.

What is it derived from?

It is based on the ACTH(4-10) fragment with an added Pro-Gly-Pro sequence for stability.

How is it supplied?

As a pack of 10 vials, wholesale, with a £300 minimum order and £45 flat worldwide shipping.


Provided for research professionals. Semax and all compounds referenced are intended strictly for in-vitro laboratory research and are not for human consumption. Verify all claims against primary literature and confirm local regulations before purchase.


Related: Cognitive research peptides · Lab standards & purity testing · Shop all research peptides · How to buy research peptides wholesale

Posted on Leave a comment

CJC-1295 / Ipamorelin Research Peptides: What They Are and What the Research Investigates

In short: CJC-1295 and Ipamorelin are synthetic research peptides studied in pre-clinical models of growth-hormone secretagogue signalling, often referenced together as a blend. They are supplied strictly for laboratory research and are not approved for human use. For research buyers, the key purchasing criteria are verified purity (≥99% HPLC), confirmed identity (mass spectrometry) and batch traceability.

What are CJC-1295 and Ipamorelin?

CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH), modified to extend its half-life. Ipamorelin is a selective growth-hormone secretagogue that acts on the ghrelin receptor through a separate pathway. Because they engage different receptor families, the two are frequently studied together. Both are research compounds only and are not medicines — they are not approved for therapeutic or human use.

What does the research investigate?

Published pre-clinical literature has examined GHRH analogues and ghrelin-receptor secretagogues in models of growth-hormone release and downstream signalling, with the combination studied for complementary receptor activity. Important: this research is largely in-vitro or in animals; findings in such models do not establish safety or efficacy in humans. Always read the primary sources directly.

Purity and quality: what research buyers should check

For reproducible research, compound quality is everything:

  • ≥99% purity by HPLC — confirm via the batch Certificate of Analysis.
  • Identity by mass spectrometry — confirms the correct molecular weight.
  • Batch numbering — traceability to a tested lot.

Vexar Lab supplies CJC-1295, Ipamorelin and the CJC-1295/Ipamorelin blend as packs of 10 vials, ≥99% HPLC-verified, batch-numbered, with mass-spec confirmation.

Handling and storage

Follow standard lyophilised-peptide practice: store sealed vials appropriately, reconstitute with the diluent specified by your method, and record batch numbers in your lab notes.

Wholesale supply

CJC-1295 and Ipamorelin are available wholesale: packs of 10 vials, £300 minimum order, bulk pricing on volume, £45 flat worldwide shipping, and optional custom labelling for resellers.

Frequently asked questions

Are these approved for human use?

No. They are research compounds supplied for in-vitro laboratory research only and are not approved for human consumption.

Why are CJC-1295 and Ipamorelin studied together?

They act on different receptor pathways, which is why the research literature often references the combination.

How are they supplied?

As packs of 10 vials, wholesale, with a £300 minimum order and £45 flat worldwide shipping.


Provided for research professionals. CJC-1295, Ipamorelin and all compounds referenced are intended strictly for in-vitro laboratory research and are not for human consumption. Verify all claims against primary literature and confirm local regulations before purchase.


Related: Growth & IGF research peptides · Lab standards & purity testing · Shop all research peptides · How to buy research peptides wholesale

Posted on Leave a comment

Retatrutide Research Peptide: What It Is and What the Research Investigates

In short: Retatrutide is a synthetic single-peptide triple receptor agonist studied as an investigational compound for GLP-1, GIP and glucagon receptor signalling. It is supplied strictly for laboratory research and is not approved for human use. For research buyers, the key purchasing criteria are verified purity (≥99% HPLC), confirmed identity (mass spectrometry) and batch traceability.

What is Retatrutide?

Retatrutide (also referenced as LY3437943) is a 39-amino-acid synthetic peptide engineered to act on three receptors simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon. As a research compound it is studied for metabolic-pathway signalling. It is an investigational compound and is not an approved medicine — it is not approved for therapeutic or human use.

What does the research investigate?

Retatrutide has been the subject of published clinical-trial literature investigating triple-receptor agonism in metabolic models, including phase-2 studies of body-weight and glycaemic endpoints and liver-fat reduction. Because this is an actively investigated, unapproved compound, the published data are evolving. Important: clinical research conducted under regulated trial conditions does not authorise use of research-grade material outside the laboratory. Always read the primary sources directly.

Purity and quality: what research buyers should check

For reproducible research, compound quality is everything:

  • ≥99% purity by HPLC — confirm via the batch Certificate of Analysis.
  • Identity by mass spectrometry — confirms the correct molecular weight.
  • Batch numbering — traceability to a tested lot.

Vexar Lab supplies Retatrutide as a pack of 10 vials, ≥99% HPLC-verified, batch-numbered, with mass-spec confirmation.

Handling and storage

Follow standard lyophilised-peptide practice: store sealed vials appropriately, reconstitute with the diluent specified by your method, and record batch numbers in your lab notes.

Wholesale supply

Retatrutide is available wholesale: packs of 10 vials, £300 minimum order, bulk pricing on volume, £45 flat worldwide shipping, and optional custom labelling for resellers.

Frequently asked questions

Is Retatrutide an approved drug?

No. It is an investigational compound supplied for in-vitro laboratory research only and is not approved for human consumption.

What makes it a “triple agonist”?

It is engineered to bind and activate three receptors — GLP-1, GIP and glucagon — within a single peptide.

How is it supplied?

As a pack of 10 vials, wholesale, with a £300 minimum order and £45 flat worldwide shipping.


Provided for research professionals. Retatrutide and all compounds referenced are intended strictly for in-vitro laboratory research and are not for human consumption. Verify all claims against primary literature and confirm local regulations before purchase.


Related: GLP-1 research peptides · Lab standards & purity testing · Shop all research peptides · How to buy research peptides wholesale

Posted on Leave a comment

GHK-Cu Research Peptide: What It Is and What the Research Investigates

In short: GHK-Cu is a copper-binding tripeptide studied in pre-clinical (in-vitro and animal) models of collagen synthesis, wound healing and skin regeneration. It is supplied strictly for laboratory research and is not approved for human use. For research buyers, the key purchasing criteria are verified purity (≥99% HPLC), confirmed identity (mass spectrometry) and batch traceability.

What is GHK-Cu?

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a copper-binding tripeptide first identified in human blood plasma, where it occurs naturally and declines with age. As a research compound it is studied for its role as a signalling molecule in tissue-repair pathways. It is used as a research compound only and is not a medicine — it is not approved for therapeutic, cosmetic or human use.

What does the research investigate?

Published pre-clinical literature has examined GHK and GHK-Cu in models of Type I and Type III collagen synthesis, fibroblast proliferation, angiogenesis, antioxidant and anti-inflammatory signalling, and wound-healing kinetics. Several in-vitro studies report effects on collagen production and cellular pathways involved in skin remodelling. Important: much of this work is in-vitro or in animal/tissue models; such findings do not establish safety or efficacy in humans. Always read the primary sources directly.

Purity and quality: what research buyers should check

For reproducible research, compound quality is everything:

  • ≥99% purity by HPLC — confirm via the batch Certificate of Analysis.
  • Identity by mass spectrometry — confirms the correct molecular weight.
  • Batch numbering — traceability to a tested lot.

Vexar Lab supplies GHK-Cu as a pack of 10 vials, ≥99% HPLC-verified, batch-numbered, with mass-spec confirmation.

Handling and storage

Copper peptides are light- and oxidation-sensitive. Follow standard lyophilised-peptide practice: store sealed vials appropriately and protected from light, reconstitute with the diluent specified by your method, and record batch numbers in your lab notes.

Wholesale supply

GHK-Cu is available wholesale: packs of 10 vials, £300 minimum order, bulk pricing on volume, £45 flat worldwide shipping, and optional custom labelling for resellers.

Frequently asked questions

Is GHK-Cu approved for human or cosmetic use?

No. It is a research compound supplied for in-vitro laboratory research only and is not approved for human consumption or cosmetic application.

Why is it called a copper peptide?

GHK forms a stable complex with copper ions; the copper is integral to the molecule studied in the research literature.

How is it supplied?

As a pack of 10 vials, wholesale, with a £300 minimum order and £45 flat worldwide shipping.


Provided for research professionals. GHK-Cu and all compounds referenced are intended strictly for in-vitro laboratory research and are not for human consumption. Verify all claims against primary literature and confirm local regulations before purchase.


Related: Healing & Recovery research peptides · Lab standards & purity testing · Shop all research peptides · How to buy research peptides wholesale